Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 8th May 2024 CTMX stock ended at $4.19. This is 2.95% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 10.95% from a day low at $3.79 to a day high of $4.21.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Nov 23, 2016 $11.52 $12.07 $11.33 $12.03 55 763
Nov 22, 2016 $11.90 $12.04 $11.54 $11.65 236 407
Nov 21, 2016 $11.81 $11.94 $11.52 $11.83 76 744
Nov 18, 2016 $11.56 $12.35 $11.48 $11.72 73 300
Nov 17, 2016 $11.27 $11.76 $11.02 $11.51 105 380
Nov 16, 2016 $11.48 $11.90 $11.20 $11.29 108 768
Nov 15, 2016 $11.33 $11.60 $11.23 $11.48 177 174
Nov 14, 2016 $11.37 $11.50 $10.91 $11.31 172 952
Nov 11, 2016 $11.12 $11.45 $10.92 $11.21 211 760
Nov 10, 2016 $11.24 $11.40 $10.77 $10.99 224 810
Nov 09, 2016 $10.84 $11.21 $10.84 $11.00 167 452
Nov 08, 2016 $10.95 $10.95 $9.85 $10.62 289 718
Nov 07, 2016 $11.14 $11.59 $11.14 $11.28 209 600
Nov 04, 2016 $10.05 $11.45 $10.05 $10.96 89 700
Nov 03, 2016 $11.30 $11.75 $10.79 $10.95 53 300
Nov 02, 2016 $11.60 $11.63 $11.15 $11.26 52 800
Nov 01, 2016 $11.90 $11.90 $11.37 $11.62 42 800
Oct 31, 2016 $11.59 $11.78 $11.11 $11.27 71 700
Oct 28, 2016 $11.75 $11.91 $11.47 $11.61 73 700
Oct 27, 2016 $11.95 $12.12 $11.48 $11.84 131 000
Oct 26, 2016 $12.66 $12.66 $11.91 $12.00 77 300
Oct 25, 2016 $12.58 $12.73 $12.13 $12.49 46 900
Oct 24, 2016 $12.98 $13.00 $12.51 $12.56 64 100
Oct 21, 2016 $12.80 $13.02 $12.76 $12.85 58 700
Oct 20, 2016 $12.71 $13.00 $12.71 $12.89 47 100
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT